Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $36.91 million. The enterprise value is $35.63 million.
Important Dates
The last earnings date was Friday, February 13, 2026, after market close.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 77.70 million shares outstanding. The number of shares has increased by 63.25% in one year.
| Current Share Class | 77.70M |
| Shares Outstanding | 77.70M |
| Shares Change (YoY) | +63.25% |
| Shares Change (QoQ) | +18.63% |
| Owned by Insiders (%) | 4.87% |
| Owned by Institutions (%) | 15.34% |
| Float | 65.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 20.73 |
| PB Ratio | 6.23 |
| P/TBV Ratio | 6.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.59 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -331.77% and return on invested capital (ROIC) is -191.16%.
| Return on Equity (ROE) | -331.77% |
| Return on Assets (ROA) | -149.81% |
| Return on Invested Capital (ROIC) | -191.16% |
| Return on Capital Employed (ROCE) | -332.36% |
| Weighted Average Cost of Capital (WACC) | 3.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$495,907 |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.37% in the last 52 weeks. The beta is -0.19, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -56.37% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 53.71 |
| Average Volume (20 Days) | 199,268 |
Short Selling Information
The latest short interest is 284,006, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 284,006 |
| Short Previous Month | 402,098 |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.43% |
| Short Ratio (days to cover) | 1.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.86M |
| Pretax Income | -26.78M |
| Net Income | -26.78M |
| EBITDA | -25.30M |
| EBIT | -26.86M |
| Earnings Per Share (EPS) | -$0.49 |
Full Income StatementBalance Sheet
The company has $2.94 million in cash and $504,000 in debt, with a net cash position of $2.43 million or $0.03 per share.
| Cash & Cash Equivalents | 2.94M |
| Total Debt | 504,000 |
| Net Cash | 2.43M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 5.88M |
| Book Value Per Share | 0.08 |
| Working Capital | 1.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.25 million and capital expenditures -$3.88 million, giving a free cash flow of -$26.12 million.
| Operating Cash Flow | -22.25M |
| Capital Expenditures | -3.88M |
| Free Cash Flow | -26.12M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
